DK169546B1 - 1,2,4-triazolonderivater, en fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne - Google Patents

1,2,4-triazolonderivater, en fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne Download PDF

Info

Publication number
DK169546B1
DK169546B1 DK468284A DK468284A DK169546B1 DK 169546 B1 DK169546 B1 DK 169546B1 DK 468284 A DK468284 A DK 468284A DK 468284 A DK468284 A DK 468284A DK 169546 B1 DK169546 B1 DK 169546B1
Authority
DK
Denmark
Prior art keywords
formula
compound
pharmaceutically acceptable
pharmaceutical composition
acid
Prior art date
Application number
DK468284A
Other languages
Danish (da)
English (en)
Other versions
DK468284D0 (da
DK468284A (da
Inventor
Richard E Gammans
David W Smith
Joseph P Yevich
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK169546(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of DK468284D0 publication Critical patent/DK468284D0/da
Publication of DK468284A publication Critical patent/DK468284A/da
Application granted granted Critical
Publication of DK169546B1 publication Critical patent/DK169546B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK468284A 1983-09-30 1984-09-28 1,2,4-triazolonderivater, en fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne DK169546B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53802783 1983-09-30
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (3)

Publication Number Publication Date
DK468284D0 DK468284D0 (da) 1984-09-28
DK468284A DK468284A (da) 1985-03-31
DK169546B1 true DK169546B1 (da) 1994-11-28

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
DK468284A DK169546B1 (da) 1983-09-30 1984-09-28 1,2,4-triazolonderivater, en fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne

Country Status (25)

Country Link
US (1) US4613600A (en:Method)
JP (1) JPS60100560A (en:Method)
KR (1) KR880002624B1 (en:Method)
AT (1) AT387963B (en:Method)
AU (1) AU561460B2 (en:Method)
BE (1) BE900714A (en:Method)
CA (1) CA1237723A (en:Method)
CH (1) CH661924A5 (en:Method)
CY (1) CY1541A (en:Method)
DE (1) DE3435745C2 (en:Method)
DK (1) DK169546B1 (en:Method)
ES (1) ES8601966A1 (en:Method)
FI (1) FI83310C (en:Method)
FR (1) FR2552759B1 (en:Method)
GB (1) GB2147297B (en:Method)
GR (1) GR80475B (en:Method)
HK (1) HK37391A (en:Method)
IE (1) IE58084B1 (en:Method)
IT (1) IT1178522B (en:Method)
LU (1) LU85561A1 (en:Method)
MY (1) MY102123A (en:Method)
NL (1) NL8402946A (en:Method)
SE (1) SE465928B (en:Method)
YU (1) YU45667B (en:Method)
ZA (1) ZA847589B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
DE60028955T2 (de) * 1999-04-09 2007-07-05 Sepracor Inc., Marlborough R-hydroxynefazodon
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
WO2000061129A2 (en) * 1999-04-09 2000-10-19 Sepracor Inc. S-hydroxynefazodone
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
EP2753179A4 (en) 2011-09-09 2015-03-04 Univ Leland Stanford Junior TOPICAL ITRACONAZOLE FORMULATIONS AND THEIR USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
FI83310B (fi) 1991-03-15
JPH0542435B2 (en:Method) 1993-06-28
CY1541A (en) 1991-03-22
GR80475B (en) 1985-01-31
CH661924A5 (de) 1987-08-31
YU172184A (en) 1986-10-31
DK468284D0 (da) 1984-09-28
FR2552759A1 (fr) 1985-04-05
KR880002624B1 (ko) 1988-12-07
IT8422922A0 (it) 1984-09-28
FR2552759B1 (fr) 1988-10-07
DE3435745A1 (de) 1985-04-11
ES536286A0 (es) 1985-11-16
JPS60100560A (ja) 1985-06-04
SE8404869D0 (sv) 1984-09-28
FI83310C (fi) 1991-06-25
FI843779A0 (fi) 1984-09-26
ES8601966A1 (es) 1985-11-16
AT387963B (de) 1989-04-10
IE58084B1 (en) 1993-06-30
ZA847589B (en) 1985-05-29
SE8404869L (sv) 1985-03-31
NL8402946A (nl) 1985-04-16
GB2147297B (en) 1987-04-15
US4613600A (en) 1986-09-23
AU561460B2 (en) 1987-05-07
KR850002270A (ko) 1985-05-10
FI843779L (fi) 1985-03-31
HK37391A (en) 1991-05-24
DK468284A (da) 1985-03-31
ATA310884A (de) 1988-09-15
AU3364884A (en) 1985-04-04
MY102123A (en) 1992-03-31
BE900714A (fr) 1985-03-28
IE842476L (en) 1985-03-30
DE3435745C2 (de) 1994-11-03
GB8424535D0 (en) 1984-11-07
CA1237723A (en) 1988-06-07
SE465928B (sv) 1991-11-18
YU45667B (sh) 1992-07-20
GB2147297A (en) 1985-05-09
IT1178522B (it) 1987-09-09
LU85561A1 (fr) 1985-06-04

Similar Documents

Publication Publication Date Title
DK169546B1 (da) 1,2,4-triazolonderivater, en fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
US4695578A (en) 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
US4487773A (en) 1,2,4-Triazol-3-one antidepressants
CA2012628C (fr) Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2501690A1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
EA002778B1 (ru) СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ
PL178546B1 (pl) Nowe, zasadniczo czyste optycznie, enancjomery prawoskrętne lub lewoskrętne 1-[(4-chlorofenylo)fenylometylo] piperazyny i sposób ich wytwarzania
EP0568437B1 (en) Antidepressant 3-Halophenylpiperazinyl-propyl Derivatives of Substituted Triazolones and Triazoldiones
HU215125B (hu) Eljárás 3-[aril-(tio)karbonil]-1-amino-alkil-1H-indol-származékokat tartalmazó, glaukóma-elleni gyógyszerkészítmények előállítására
JP2840288B2 (ja) 置換１―（１ｈ―イミダゾール―４―イル）アルキル―ベンズアミド
EA005013B1 (ru) Галогензамещённые производные 4-фенил-1-пиперазина, -пиперидина и -тетрагидропиридина
US4337250A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
JPH0657693B2 (ja) ムスカリン様レセプター拮抗薬
EP0378468B1 (fr) Dérivés des bisarylalcènes, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
US4432978A (en) Hexahydro-trans-pyridoindole
US4575555A (en) 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
HU194220B (en) Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof
US4427679A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4105768A (en) Hypotensive substituted 1,2,4-triazoles
US4431649A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
CZ289526B6 (cs) (S) nebo (R) Enantiomer piperazinylové sloučeniny a způsob jeho přípravy
JP2007517855A (ja) セロトニン及びノルアドレナリン再取込み阻害剤としての活性を示すピペラジン誘導体
JP3462234B2 (ja) 異項環化合物、その製造法、用途および合成中間体
US4431646A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
JPH05239037A (ja) セロトニン神経系関連疾患治療剤

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired